1. Quotes

    1-10 of 808 1 2 3 4 ... 79 80 81 »
    1. Publisher: physicsworld.com
      We agree that, given the images we've seen from the hardware [adaptive optics] systems, our computational approaches are equivalent to those...In addition, we think we could do better by correcting the finer aberrations and by being able to manipulate the data post-acquisition, which gives us a lot more flexibility.
      - Stephen A. Boppart in Bringing the human eye into focus
    2. Publisher: physicsworld.com
      We agree that, given the images we've seen from the hardware [adaptive optics] systems, our computational approaches are equivalent to those...In addition, we think we could do better by correcting the finer aberrations and by being able to manipulate the data post-acquisition, which gives us a lot more flexibility.
      - Stephen A. Boppart in Bringing the human eye into focus
    3. Publisher: Optical Coherence Tomography News
      Based on this pivotal research, we believe that VivoSight scans should become the gold standard for non-invasive diagnosis and monitoring of non-melanoma skin cancer...We are now expanding the availability of our new generation VivoSight scanner in Germany and select territories in Europe.
      - Andy Hill in Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma: Data to be presented at the World Congress of Dermatology in Vancouver
    4. Publisher: Optical Coherence Tomography News
      We are delighted to join Leica Microsystems. Together, we believe we can jointly leverage our ophthalmic imaging technologies, address broader research and clinical markets, and more efficiently complete the next steps in integrating OCT imaging capabilities into the operating room.
      - Eric L. Buckland in Leica Microsystems to Acquire OCT Company Bioptigen
    5. Publisher: Business Weekly
      The system is now more compact, more portable and easier to store, which will enable it to be used effectively across several consulting rooms in a single practice.
      - In Cambridge role in new medical device
    6. Publisher: optics.org
      The results of ILUMIEN II address long-standing questions regarding the ability of OCT guidance to achieve comparable stent expansion, more precise measurements and a greater level of vascular visualization than first-generation imaging tools such as intravenous ultrasound.
      - In Optical coherence tomography 'reducing heart attacks'
    7. Publisher: Optical Coherence Tomography News
      These acute results from the VISION study have exceeded even my high expectations going into the trial...Never before have we been able to see the arterial wall during atherectomy, nor have I seen these types of results, with this much control over the procedure outcomes and so little adjunctive therapy required to achieve the desired angiographic results, with only 4% of lesions treated receiving placement of a stent. Based on the data we have seen to date, I believe we continue to be on track to meet or exceed our primary safety endpoint once all six-month follow-up data becomes available.
      - John B. Simpson in Avinger Announces 30-Day VISION Trial Results at EuroPCR 2015
    8. Publisher: fiercemedicaldevices.com
      The results of ILUMIEN II address long-standing questions regarding the ability of OCT guidance to achieve comparable stent expansion, more precise measurements and a greater level of vascular visualization than first generation imaging tools such as IVUS.
      - In St. Jude says alternative imaging system is optimal during stenting procedures
    9. Publisher: optics.org
      The ophthalmic optical coherence tomography (OCT) application was one of the key drivers.
      - In GSI outlines post-JK strategy
    10. Publisher: optics.org
      The precision motion business was stronger than we had forecasted.
      - In GSI outlines post-JK strategy
    1-10 of 808 1 2 3 4 ... 79 80 81 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Most Quoted Topics